Our Stem Cell Sector Companies financials page has been updated for the quarter ended June 30. Pluristem has not submitted financials for its fiscal year ended June 30, 2008. Thermogenesis Corp. (KOOL) revenues for the fiscal year exceeded 20 million dollars, the first company in our stem cell sector to do so. While not yet profitable, Thermogenesis projects that breakeven operations will begin in quarter four of the current fiscal year.

Comments